Osteoporosis Drugs Market by Product and Geography - Forecast and Analysis 2021-2025

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Product

• Market segments
• Comparison by Product
• Antiresorptive drugs - Market size and forecast 2020-2025
• Anabolic drugs - Market size and forecast 2020-2025
• Market opportunity by Product

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Amgen Inc.
• Asahi Kasei Corp.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Radius Health Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB SA

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations